<DOC>
	<DOCNO>NCT02601560</DOCNO>
	<brief_summary>A Phase 2a Randomized , Double-blind , Placebo-controlled Study Evaluate Safety , Pharmacokinetics , Pharmacodynamics Single-Ascending Doses MEDI6012 Subjects Stable Coronary Artery Disease</brief_summary>
	<brief_title>Study Evaluate Safety , Pharmacokinetics Pharmacodynamics , MEDI6012 Subjects With Stable Coronary Artery Disease</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Men woman 40 75 year old History Stable CAD Currently receive statin standard care Severe angina pectoris symptom Highrisk coronary carotid artery disease likely require surgical percutaneous intervention study period Hospitalization heart failure within 12 month prior screen Uncontrolled Hypertension Within 6 month prior screen , history ACS hospitalization heart failure Clinically significant abnormality rhythm , conduction morphology ECG Subjects transplant heart , leave ventricular assist device , implanted pacemaker , implantable cardioverter defibrillator , cardiac resynchronization therapy Untreated lifethreatening ventricular arrhythmias History , within 12 month prior screen , myocarditis restrictive pericarditis , hemodynamically significant valvular hear disease aortic disease Undergone major surgery 3 month prior screen plan major surgery study period</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>CAD</keyword>
</DOC>